As public perception and the legality of cannabis and other novel psychoactive substances continue to evolve, what emerging risks and litigation should insurance professionals keep an eye on?
Last week, Verisk Analytics hosted a webinar to answer those questions and highlight trends associated with recreational marijuana, hemp-derived cannabis products and other substances. Subject matter experts also touched on psychedelic drugs and therapies.
Cannabis Landscape
Twenty-four states and the District of Columbia have legalized recreational cannabis. Medical cannabis is legal in 40 states. To drive home a point of continued cannabis industry enthusiasm among advocates and a growing base of opposition, Laura Panesso, associate vice president of governmental relations at Verisk, shared that 16 states propose